Zobraziť v EDS

Nya klassifikations­kriterier för antifosfolipidsyndrom: implications and clinical significance

Uložené v:
Podrobná bibliografia
Názov: Nya klassifikations­kriterier för antifosfolipidsyndrom: implications and clinical significance
New classification criteria for antiphospholipid syndrome
Autori: Hasani, Liridon, Olin, Signe, Bengtsson, Anders, Jönsen, Andreas, Ohlsson, Sophie, Elf, Johan, Strevens, Helena, Zetterberg, Eva
Prispievatelia: Lund University, Lunds universitet, Originator, Lund University, Faculty of Medicine, Department of Translational Medicine, Clinical Coagulation, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Klinisk koagulationsmedicin, Malmö, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section III, Rheumatology, Lund SLE Research Group, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion III, Reumatologi och molekylär skelettbiologi, Lund SLE Research Group, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EpiHealth: Epidemiology for Health, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EpiHealth: Epidemiology for Health, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section II, Nephrology, Autoimmunity and kidney diseases, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion II, Njurmedicin, Autoimmunitet och njursjukdomar, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Obstetrics and Gynaecology (Lund), Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Obstetrik och gynekologi, Lund, Originator
Zdroj: Lakartidningen. 122:1-4
Predmety: Medical and Health Sciences, Clinical Medicine, Cardiology and Cardiovascular Disease, Medicin och hälsovetenskap, Klinisk medicin, Kardiologi och kardiovaskulära sjukdomar
Popis: The new ACR/EULAR classification criteria for APS differ from the previous Sydney criteria by incorporating a broader range of clinical manifestations beyond venous/arterial thromboembolism and obstetric complications. These include microvascular disease, heart valve disease and thrombocytopenia. We applied both classification systems to a cohort of 139 individuals diagnosed with primary APS in Southern Sweden. Of these, 76 met the ACR/EULAR criteria, while 78 fulfilled the Sydney criteria. Subsequently, only a marginal difference in diagnostic yield was observed between the two classification systems. However, the ACR/EULAR criteria are particularly advantageous as they provide clear definitions and encompass a broader spectrum of clinical manifestations, aligning more closely with the clinical management of patients with APS compared to the Sydney criteria.
Prístupová URL adresa: https://media.arto.se/app/uploads/sites/11/2025/09/09132330/24149.pdf
Databáza: SwePub
Popis
Abstrakt:The new ACR/EULAR classification criteria for APS differ from the previous Sydney criteria by incorporating a broader range of clinical manifestations beyond venous/arterial thromboembolism and obstetric complications. These include microvascular disease, heart valve disease and thrombocytopenia. We applied both classification systems to a cohort of 139 individuals diagnosed with primary APS in Southern Sweden. Of these, 76 met the ACR/EULAR criteria, while 78 fulfilled the Sydney criteria. Subsequently, only a marginal difference in diagnostic yield was observed between the two classification systems. However, the ACR/EULAR criteria are particularly advantageous as they provide clear definitions and encompass a broader spectrum of clinical manifestations, aligning more closely with the clinical management of patients with APS compared to the Sydney criteria.
ISSN:00237205
16527518